BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36870436)

  • 1. Acceptability and Preferences of Dry HR HPV Self-Sampling Mailed Kits Among Canadian Women: A Cross-Sectional Study.
    Ruel-Laliberté J; Jacob-Wagner M; Bestman-Smith J; Paré J
    J Obstet Gynaecol Can; 2023 Apr; 45(4):261-266. PubMed ID: 36870436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acceptability and Feasibility of HPV Self-Sampling as an Alternative Primary Cervical Cancer Screening in Under-Screened Population Groups: A Cross-Sectional Study.
    Wong EL; Cheung AW; Wong AY; Chan PK
    Int J Environ Res Public Health; 2020 Aug; 17(17):. PubMed ID: 32867315
    [No Abstract]   [Full Text] [Related]  

  • 3. Mailing human papillomavirus self-sampling kits to women under-screened for cervical cancer improved detection in cervical cancer screening in a general population study in Japan.
    Nishimura Y; Matsuura M; Terada N; Nagao S; Shimada H; Isoyama K; Tamate M; Iwasaki M; Saito T
    BMC Public Health; 2023 Mar; 23(1):473. PubMed ID: 36906527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-sectional study of HPV testing in self-sampled urine and comparison with matched vaginal and cervical samples in women attending colposcopy for the management of abnormal cervical screening.
    Sargent A; Fletcher S; Bray K; Kitchener HC; Crosbie EJ
    BMJ Open; 2019 Apr; 9(4):e025388. PubMed ID: 31036707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leveraging COVID-era innovation for cervical cancer screening: Clinician awareness and attitudes toward self-sampling and rapid testing for HPV detection.
    Rodriguez NM; Brennan LP; Claure L; Balian LN; Champion VL; Forman MR
    PLoS One; 2023; 18(3):e0282853. PubMed ID: 36893182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation of HPV-based Cervical Cancer Screening Combined with Self-sampling Using a Midwifery Network Across Rural Greece: The GRECOSELF Study.
    Agorastos T; Chatzistamatiou K; Tsertanidou A; Mouchtaropoulou E; Pasentsis K; Kitsou A; Moysiadis T; Moschaki V; Skenderi A; Katsiki E; Aggelidou S; Venizelos I; Ntoula M; Daponte A; Vanakara P; Garas A; Stefos T; Vrekoussis T; Lymberis V; Kontomanolis EN; Makrigiannakis A; Manidakis G; Deligeoroglou E; Panoskaltsis T; Decavalas GO; Michail G; Kalogiannidis I; Koukoulis G; Zempili P; Halatsi D; Truva T; Piha V; Agelena G; Chronopoulou A; Vaitsi V; Chatzaki E; Paschopoulos M; Adonakis G; Kaufmann AM; Hadzidimitriou A; Stamatopoulos K
    Cancer Prev Res (Phila); 2019 Oct; 12(10):701-710. PubMed ID: 31427275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acceptability of self-collected vaginal samples for human papillomavirus testing for primary cervical cancer screening: comparison of face-to-face and online recruitment modes.
    Ngu SF; Lau LS; Chan CY; Ngan HY; Cheung AN; Chan KK
    BMC Public Health; 2024 Apr; 24(1):1104. PubMed ID: 38649876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mailed Human Papillomavirus Self-Collection With Papanicolaou Test Referral for Infrequently Screened Women in the United States.
    Smith JS; Des Marais AC; Deal AM; Richman AR; Perez-Heydrich C; Yen-Lieberman B; Barclay L; Belinson J; Rinas A; Brewer NT
    Sex Transm Dis; 2018 Jan; 45(1):42-48. PubMed ID: 28876298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinician acceptability of self-collected human papillomavirus swabs as a primary cervical cancer screening method.
    Zelli J; Hum S; Lofters A; Dunn S
    Can Fam Physician; 2022 Feb; 68(2):e31-e38. PubMed ID: 35177513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acceptability of vaginal self-sampling with high-risk human papillomavirus testing for cervical cancer screening: a French questionnaire-based study.
    Bertucci M; Bonnet E; Satger L; Kreiche A; Chappert JL; Loy-Morel S; Segondy M; Daurès JP; Boulle N
    Women Health; 2021 Jan; 61(1):83-94. PubMed ID: 33106125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of two invitation-based methods for human papillomavirus (HPV) self-sampling with usual care among un- and under-screened Māori, Pacific and Asian women: study protocol for a randomised controlled community trial to examine the effect of self-sampling on participation in cervical-cancer screening.
    Brewer N; Bartholomew K; Maxwell A; Grant J; McPherson G; Wihongi H; Bromhead C; Scott N; Crengle S; Cunningham C; Douwes J; Potter JD
    BMC Cancer; 2019 Dec; 19(1):1198. PubMed ID: 31815615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized Intervention of Self-Collected Sampling for Human Papillomavirus Testing in Under-Screened Rural Women: Uptake of Screening and Acceptability.
    Racey CS; Gesink DC; Burchell AN; Trivers S; Wong T; Rebbapragada A
    J Womens Health (Larchmt); 2016 May; 25(5):489-97. PubMed ID: 26598955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A conjoint analysis study on self-sampling for human papillomavirus (HPV) testing characteristics among black women in Indiana.
    Biederman E; Champion V; Zimet G
    BMC Womens Health; 2020 Mar; 20(1):55. PubMed ID: 32192493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Utilization of self-sampling kits for HPV testing in cervical cancer screening - pilot study].
    Ondryášová H; Koudeláková V; Drábek J; Vaněk P; Slavkovský R; Hajdúch M
    Ceska Gynekol; 2015 Dec; 80(6):436-43. PubMed ID: 26741158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventing cervical cancer using HPV self-sampling: direct mailing of test-kits increases screening participation more than timely opt-in procedures - a randomized controlled trial.
    Tranberg M; Bech BH; Blaakær J; Jensen JS; Svanholm H; Andersen B
    BMC Cancer; 2018 Mar; 18(1):273. PubMed ID: 29523108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reach and effectiveness of an HPV self-sampling intervention for cervical screening amongst under- or never-screened women in Toronto, Ontario Canada.
    Devotta K; Vahabi M; Prakash V; Lofters A
    BMC Womens Health; 2023 Jan; 23(1):36. PubMed ID: 36698140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer.
    Wright TC; Denny L; Kuhn L; Pollack A; Lorincz A
    JAMA; 2000 Jan; 283(1):81-6. PubMed ID: 10632284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mailed self-sample HPV testing kits to improve cervical cancer screening in a safety net health system: protocol for a hybrid effectiveness-implementation randomized controlled trial.
    Montealegre JR; Anderson ML; Hilsenbeck SG; Chiao EY; Cantor SB; Parker SL; Daheri M; Bulsara S; Escobar B; Deshmukh AA; Jibaja-Weiss ML; Zare M; Scheurer ME
    Trials; 2020 Oct; 21(1):872. PubMed ID: 33087164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of vaginal self-sampling on cervical cancer screening rates: a community-based study in Newfoundland.
    Duke P; Godwin M; Ratnam S; Dawson L; Fontaine D; Lear A; Traverso-Yepez M; Graham W; Ravalia M; Mugford G; Pike A; Fortier J; Peach M
    BMC Womens Health; 2015 Jun; 15():47. PubMed ID: 26060041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study.
    Gök M; Heideman DA; van Kemenade FJ; Berkhof J; Rozendaal L; Spruyt JW; Voorhorst F; Beliën JA; Babovic M; Snijders PJ; Meijer CJ
    BMJ; 2010 Mar; 340():c1040. PubMed ID: 20223872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.